Home › Therapeutic areas › Oncology › Neurofibromatosis Type 1
Neurofibromatosis Type 1 (1 companies)
Companies with an active program in Neurofibromatosis Type 1.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | NeurologyOncology | 1 | Phase 1 | 3 |
No companies match.